R. Lor Randall MD
Musculoskeletal Oncology/Cancer, Pediatric Orthopedics
Professor & Chair, The David Linn Endowed Chair in Orthopaedic Surgery, Department of Orthopaedic Surgery, Sarcoma Services, University of California, Davis Health
Join to view full profile
4860 Y Street Suite 3800Sacramento, CA 95817
Phone+1 916-734-2958
Dr. Randall is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My clinical practice and research focuses on musculoskeletal surgical oncology and on building-leading edge trans-disciplinary teams to combat rare cancers of connective tissue in children and adults.
Education & Training
University of California (San Francisco)Residency, Orthopaedic Surgery, 1992 - 1997
Yale School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2028
UT State Medical License 1998 - 2020
WA State Medical License 1997 - 2020
American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification HELP2 Clinical Desktop, Intermountain Healthcare, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial.Sapna Oberoi, Zhengya Gao, Wei Xue, Robert L Randall, Cheryl M Coffin
Journal of the National Cancer Institute. 2026-06-27 - Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Childr...Safia K Ahmed, Odion Binitie, Mark Krailo, Daniel J Indelicato, Alexandra K Callan
International Journal of Radiation Oncology, Biology, Physics. 2026-06-01 - A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.Katherine A Janeway, Alexander J Chou, Allen Buxton, Joel Reid, Michael S Isakoff
Clinical Cancer Research. 2026-01-06
Authored Content
- AAOS 2021: A Much-Needed Shot in the ArmSeptember 2021
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
